跳至主要内容
临床试验/NL-OMON55124
NL-OMON55124招募中不适用

The diagnostic value of Metabolic Hyperspectral Imaging of the Retina in Alzheimer's disease (MHIRA). - MHIRA

Vrije Universiteit Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Aged 50-90 years
  • - Participant had amyloid PET scan preferably within 1 year of inclusion in
  • - Mini mental state exam >17 (i.e. patients are mentally competent)

排除标准

  • * Pupil dilation inadequate or contraindicated.
  • * Presence of glaucoma, retinal vascular occlusion or retinopathy (diabetic,
  • hypertensive).
  • * Presence of moderate / late stage age-related macular degeneration.
  • * Media opacities (cataract) precluding a good quality imaging
  • * Refractive error outside the range -6 D to +6 D.
  • * Inability to obtain good quality images with the MHRC.
  • * Ocular conditions that could influence tear biochemical parameters (including
  • eye infection, eye inflammation, eye surgery within the last 28 days or other
  • acute eye conditions).

研究者

相似试验